Health officials in China are investigating a batch of blood plasma treatments that were reportedly infected with HIV.
China’s National Health Commission released a statement on Tuesday instructing “medical institutions across the country” to stop using a batch of human immunoglobulin distributed by Shanghai Xinxing Pharmaceutical after it received reports of positive HIV tests. Read More